Literature DB >> 8003849

Inhibitors of cyclic nucleotide phosphodiesterase isoenzymes--their potential utility in the therapy of asthma.

C D Nicholson1, M Shahid.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 8003849     DOI： 10.1006/pulp.1994.1001

Source DB:  PubMed          Journal:  Pulm Pharmacol        ISSN： 0952-0600


× No keyword cloud information.
  25 in total

1.  The effect of isoenzyme-selective PDE inhibitors on methacholine-induced contraction of guinea-pig and rat ileum.

Authors:  A Tomkinson; D Raeburn
Journal:  Br J Pharmacol       Date:  1996-08       Impact factor: 8.739

2.  Effects of SCA40 on human isolated bronchus and human polymorphonuclear leukocytes: comparison with rolipram, SKF94120 and levcromakalim.

Authors:  J Cortijo; V Villagrasa; C Navarrete; C Sanz; L Berto; A Michel; P A Bonnet; E J Morcillo
Journal:  Br J Pharmacol       Date:  1996-09       Impact factor: 8.739

Review 3.  Phosphodiesterase 4 inhibitors and the treatment of asthma: where are we now and where do we go from here?

Authors:  M A Giembycz
Journal:  Drugs       Date:  2000-02       Impact factor: 9.546

4.  Stimulation of the hypothalamo-pituitary-adrenal axis in the rat by the type 4 phosphodiesterase (PDE-4) inhibitor, denbufylline.

Authors:  A J Hadley; M Kumari; P O Cover; J Osborne; R Poyser; J D Flack; J C Buckingham
Journal:  Br J Pharmacol       Date:  1996-10       Impact factor: 8.739

5.  Effects of selective phosphodiesterase inhibitors on platelet-activating factor- and antigen-induced airway hyperreactivity, eosinophil accumulation, and microvascular leakage in guinea pigs.

Authors:  J L Ortiz; J M Vallés; M Martí-Cabrera; J Cortijo; E J Morcillo
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1996-01       Impact factor: 3.000

6.  Inhibition of bronchospasm and ozone-induced airway hyperresponsiveness in the guinea-pig by CDP840, a novel phosphodiesterase type 4 inhibitor.

Authors:  M Holbrook; N Gozzard; T James; G Higgs; B Hughes
Journal:  Br J Pharmacol       Date:  1996-07       Impact factor: 8.739

7.  Effect of the glucocorticosteroid budesonide and a novel phosphodiesterase type 4 inhibitor CDP840 on antigen-induced airway responses in neonatally immunised rabbits.

Authors:  N Gozzard; A el-Hashim; C M Herd; S M Blake; M Holbrook; B Hughes; G A Higgs; C P Page
Journal:  Br J Pharmacol       Date:  1996-07       Impact factor: 8.739

8.  Cyclic nucleotide phosphodiesterase (PDE) isoenzymes in the human detrusor smooth muscle. II. Effect of various PDE inhibitors on smooth muscle tone and cyclic nucleotide levels in vitro.

Authors:  M C Truss; S Uckert; C G Stief; W G Forssmann; U Jonas
Journal:  Urol Res       Date:  1996

9.  Effects of phosphodiesterase inhibitors on interleukin-4 and interleukin-13 generation from human basophils.

Authors:  Nahid Eskandari; Thulani Wickramasinghe; Peter T Peachell
Journal:  Br J Pharmacol       Date:  2004-07-20       Impact factor: 8.739

Review 10.  Phosphodiesterase-4 inhibitors in the treatment of inflammatory lung disease.

Authors:  Domenico Spina
Journal:  Drugs       Date:  2003       Impact factor: 9.546
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.